31P-spectroscopy of frontal lobe in schizophrenia: Alterations in phospholipid and high-energy phosphate metabolism

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 117-122

  Yacubian, Juliana ^a   De Castro, Claudio Campi ^a   Ometto, Mariella ^a   Barbosa, Elizabeth ^a   De Camargo, Cândida Pires ^a   Tavares Jr , Hildeberto ^a   Cerri, Giovanni Guido ^a   Gattaz, Wagner Farid ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

31 Phosphorus spectroscopy; Frontal lobe; High energy phosphate; Negative symptoms; Neuropsychology; Phospholipid; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; ESTER DERIVATIVE; MEMBRANE PHOSPHOLIPID; PHOSPHATE; PHOSPHOLIPASE A;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRONTAL LOBE; HIGH ENERGY PHOSPHATE; HUMAN; INTELLIGENCE TEST; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROPHYSIOLOGY; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; WISCONSIN CARD SORTING TEST; BRIEF PSYCHIATRIC RATING SCALE; COGNITIVE DEFECT; ENERGY METABOLISM; METABOLISM; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY;

ADULT; BRIEF PSYCHIATRIC RATING SCALE; COGNITION DISORDERS; ENERGY METABOLISM; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEUROPSYCHOLOGICAL TESTS; PHOSPHATES; PHOSPHOLIPASES A; SCHIZOPHRENIA;

EID: 0036882333     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00394-2     Document Type: Article

References (29)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th Edn. 1994;American Psychiatric Press, Washington, DC.
2. Andreasen N.C., O'Leary D.S., Flaum M., Nopoulos P., Watkins G.L., Boles Ponto L.L., Hichwa R.D. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients. Lancet. 14(394):1997;1730-1734.
3. 31P-MRS of the schizophrenic brain in vivo. J. Comput. Assisted Tomogr. 23:1999;272-275.
4. Borowoski G.J., Benton A.L., Spreen O. Word fluency and brain damage. Neuropsychologia. 5:1967;135-140.
5. 31Phosphorus magnetic resonance spectroscopy of frontal and parietal lobes in chronic schizophrenia. Biol. Psychiatry. 152:1994;126-129.
6. Fukuzako H. Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J. Biol. Psychiatry. 2:2001;70-82.
7. 2 activity in schizophrenics patients: reduction after neuroleptic therapy. Biol. Psychiatry. 7(22):1987;421-426.
8. Gattaz W.F., Mayer S., Ziegler P., Platz M., Gasser T. Hypofrontality on topographic EEG in schizophrenia. Correlations with neuropsychological and psychopathological parameters. Eur. Arch. Psychiatry Clin. Neurosci. 241(6):1992;328-332.
9. 2 activity in schizophrenia. Schizophr. Res. 16:1995;1-6.
10. Hazlett, E.A., Buchsbaum, M.S., Jeu, L.A., Nenadic, I., Fleischman, M.B., Shihabuddin, L., Haznedar, M.M., Harvey, P.D., 2000. Hypofrontality in unmedicated schizophrenia patients studied with PET during performance serial verbal learning task. Schizophr. Res. 43 (1), 33-46.
11. Heaton R.K. The Wisconsin Card Sorting Test Manual. 1981;Psychological Assessment Resources, Odessa, FL.
12. Iager A.C., Kirch D.G., Wyatt R.J. A negative symptom rating scale. Psychiatry Res. 16:1985;27-36.
13. Keshavan M.S., Stanley J.A., Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia methodological issues and findings - Part II. Biol. Psychiatry. 48:2000;369-380.
14. 31P-NMR study of brain phospholipid structures in vivo. Biochim. Biophys. Acta. 1085:1991;257-264.
15. Medved V., Petrovic R., Isgum V., Szirovicza I., Hotujac L. Similarities in the pattern of regional brain dysfunction in negative schizophrenia and unipolar depression: a single photon emission-computed tomography and auditory evoked potential. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 25(5):2001;993-1009.
16. Myers C.S., Contreras M.A., Chang M.C., Rapoport S.I., Appel N.M. Haloperidol down regulates phospholipase A(2) signaling in rat basal ganglia circuits. Brain Res. 30:2001;96-101.
17. Ordidge R.J., Connelly A., Lohman J.A. Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy. J. Magn. Reson. 66:1986;283-294.
18. Overall J.E., Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10:1962;799-812.
19. Paulman R.G., Devous M.D. Sr., Gregory R.R., Herman J.H., Jennings L., Bonte F.J., Nasrallah H.A., Raese J.D. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biol. Psychiatry. 15(4):1999;377-399.
20. Pettegrew J.W., Keshavan M.S., Panchaligan K. Alterations in brain high energy phosphate and membrane phospholipid metabolism in first episode, drug naïve schizophrenics. Arch. Gen. Psychiatry. 48:1991;563-568.
21. Ross B.M., Hudson C., Erlich J., Warsh J.J., Kish S.J. Increased phospholipid breakdown in schizophrenia. Arch. Gen. Psychiatry. 54:1997;487-494.
22. 31P-MR spectroscopy study. Schizophr. Res. 13:1994;209-215.
23. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., Thompson R.T. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 52:1995;399-406.
24. Stanley J.A., Pettegrew J.W., Keshavan M.S. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings - Part I. Biol. Psychiatry. 48:2000;357-368.
25. Stroop J.R. Studies of interference in serial verbal reactions. J. Exp. Psychol. 18:1935;643-661.
26. Trzeciak H.I., Kalacinski W., Mlecki A., Kokot D. Effect of neuroleptics on phospholipase A2 activity in the brain of rats. Eur. Arch. Psychiatry Clin. Neurosci. 245(3):1995;179-182.
27. 31P-magneto-resonance spectroscopic study. Psychiatry Res. Neuroimaging. 76:1997;123-129.
28. 31phosphorus magnetic resonance spectroscopic and neuropsychological investigation. Schizophr. Res. 31:1998;37-47.
29. 31phosphorus magnetic resonance spectroscopy parameters. Rev. Psiquiatr. Clin. 26:1999;68-71. (www.hcnet.usp.br/ipq/revista/r263/artigo(68).htm).